Expression of Sirt1, which belongs to the sirtuin family of NAD+-dependent deacetylases, is downregulated in IBD biopsies and increased in mucosal samples of IBD patients successfully treated with Infliximab (Caruso et al., 2014). Here, SIRT1 is linked to inflammatory bowel disease.